Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Efficacy and Tolerance of Sub-cutaneous Re-injection of Autologous

NCT02866565 is registered in ClinicalTrials.gov with Assistance Publique Hopitaux De Marseille as lead sponsor.

NCT NCT02866565
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02866565 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Efficacy and Tolerance of Sub-cutaneous Re-injection of Autologous
Lead sponsor
Assistance Publique Hopitaux De Marseille
Phase
Phase 2
Overall status
Not yet recruiting
Start date
June 30, 2023
Completion date
December 31, 2026
Enrollment
45 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot ulcer